LakeShore Biopharma Co., Ltd (LSB) — Financial Flexibility Index
LakeShore Biopharma Co., Ltd (LSB) has a Financial Flexibility Index of -0.01x as of June 2022. Free cash flow of $-693.96K (operating CF $-693.96K minus capex $0.00) represents 0% of total liabilities ($76.38 Million). Also explore LSB net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LakeShore Biopharma Co., Ltd Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LakeShore Biopharma Co., Ltd across 5 annual periods. See LakeShore Biopharma Co., Ltd balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for LakeShore Biopharma Co., Ltd (2021–2025)
Year-by-year free cash flow to debt coverage for LakeShore Biopharma Co., Ltd. For the full company profile including market capitalisation, see LSB company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-103.12 Million | $-120.98 Million | $867.91 Million | ▲ +56.1% |
| 2024 | -0.27x | $-250.98 Million | $-295.23 Million | $927.82 Million | ▼ -113.8% |
| 2023 | -0.13x | $-125.42 Million | $-182.47 Million | $991.30 Million | ▼ -102.1% |
| 2022 | 6.16x | $125.39 Million | $-173.55 Million | $20.35 Million | ▲ +100.3% |
| 2021 | -2024.38x | $-141.73 Million | $-246.61 Million | $70.01K | — |